Pharmacotherapy and overdose risk following new opioid use disorder diagnosis among Medicaid beneficiaries. [PDF]
Treitler P +5 more
europepmc +1 more source
Pharmacological management of binge eating disorder. [PDF]
Williams AM.
europepmc +1 more source
Naltrexone/Bupropion, Liraglutide, or Semaglutide as Adjuvant Therapy After Metabolic and Bariatric Surgery: An Observational Study. [PDF]
Brancatisano A, Ryan B.
europepmc +1 more source
Reporting of harms in systematic reviews focused on naltrexone: a cross-sectional study. [PDF]
Schnitker J +9 more
europepmc +1 more source
Efficacy of Low Dose Naltrexone in Psoriasis
Sidra Khan, Rabia Ghafoor, Sana Kaleem
openalex +2 more sources
Seeing the bigger picture: endogenous opioids mediate attentional broadening after reward receipt. [PDF]
van Steenbergen H +5 more
europepmc +1 more source
Synergistic effects of levo-tetrahydropalmatine and low-dose naltrexone on nicotine conditioned place preference in mice: a dual-target strategy based on dopamine and opioid systems [PDF]
Feng Ke +7 more
openalex +1 more source
Distilling the evidence for GLP-1 receptor agonists in alcohol use disorder. [PDF]
Bernstein EY, Schacht JP.
europepmc +1 more source

